Hepatocellular Carcinoma in Pakistan: Where do We Stand?

@inproceedings{Butt2012HepatocellularCI,
  title={Hepatocellular Carcinoma in Pakistan: Where do We Stand?},
  author={Amna Subhan Butt and Zaigham Ali Abbas and Wasim Jafri},
  booktitle={Hepatitis monthly},
  year={2012}
}
CONTEXT From the 1970s till the mid 1990s, hepatitis B was the most common etiological factor for hepatocellular carcinoma (HCC) in Pakistan. Afterwards, a shift in HCC etiology was observed with a steady rise in hepatitis C virus (HCV) related HCC cases. HCV-3a, which is the most prevalent genotype, is also most frequent in HCV related HCC. There was an increase in the proportion of non-B non-C (NBNC) HCC cases as well, which might be attributed to an increase in non-alcoholic fatty liver… CONTINUE READING
10 Citations
55 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 55 references

Oral Capecitabine for the treatment of advanced hepatocellular carcinoma

  • MK Anis, Z Abbas, W. Jafri
  • Pakistan J Gastroenterol
  • 2011
1 Excerpt

Presentation of Hepatocellular Cancer in the Developing World: An Analysis of the Presentation and Association with Chronic Hepatitis B and C. AJG. 2011;106(supplement 2):S126

  • A Nawaz, A Chaudhry, M Riaz, M Yousaf, A Alvi, S Batool
  • 2011

sentation of Hepatocellular Cancer in the Developing World : An Analysis of the Presentation and Association with Chronic Hepatitis B and C

  • A Nawaz, A Chaudhry, M Riaz, M Yousaf, A Alvi, S Batool
  • AJG
  • 2011

Similar Papers

Loading similar papers…